Jing Zhang , Jakob Grove , Caitlin Carey , Jack Fu , F. Kyle Satterstrom , Susan Kuo , Ajay Nadig , Swapnil Awasthi , Kaitlin Samocha , Anders Børglum , Elise Robinson
{"title":"THE POLYGENETIC ARCHITECTURE OF AUTISM","authors":"Jing Zhang , Jakob Grove , Caitlin Carey , Jack Fu , F. Kyle Satterstrom , Susan Kuo , Ajay Nadig , Swapnil Awasthi , Kaitlin Samocha , Anders Børglum , Elise Robinson","doi":"10.1016/j.euroneuro.2024.08.045","DOIUrl":null,"url":null,"abstract":"<div><div>Autism is highly heritable and has been associated with multiple classes of genetic variation. Common genetic variation contributes substantially to autism. Previously, with 18,381 autistic individuals and 27,969 non-autistic individuals, five genome-wide significant loci were identified. Now with 38,717 autistic individuals and 232,725 non-autistic individuals, we report an updated genome-wide association study (GWAS) of autism with 12 genome-wide significant loci. We observe a moderate genetic correlation (0.675, SE=0.0434) between Europe-based (Nautistic=22,643; Nnon-autistic=204,389) and United States-based (Nautistic =16,074; Nnon-autistic=28,346) autism cohorts, which contributes to the decline of the estimated single nucleotide polymorphism (SNP) heritability (from 0.118 (SE=0.010) to 0.068 (SE=0.003)). The genetic correlation between autism with intellectual disability (ID) (Nautistic=6,590; Nnon-autistic= 43,071; h2=0.062; SE=0.012) and autism without ID (Nautistic=23,173; Nnon-autistic= 204,679; h2=0.089; SE=0.005) is 0.658 (SE=0.086). In the United States family-based cohorts, the genetic correlation between autism with ID (Nfamily=3,993; h2=0.159; SE=0.033) and autism without ID (Nfamily=4,357; h2=0.171; SE=0.031) is 0.812 (SE=0.157). Autism without ID was positively genetically correlated with educational attainment (0.163; P=4.84 × 10-11) and intelligence (0.233; P=1.95 × 10-11). Autism with ID genetically correlated with neither educational attainment (0.036; P=0.409) nor intelligence (-0.072; P=0.235). As ID alone is negatively genetically correlated with intelligence, the lack of correlation between autism with ID and intelligence strongly suggests that autism with ID is genetically different from ID alone. This difference has implications for both research and clinical nosology. Rare and de novo variants contribute substantially to autism in some individuals. Through rare variant analyses, 72 genes have been associated with autism at a genome-wide significant level to date. While de novo protein truncating variants (PTVs) and copy number deletions have been associated with autism, we report preliminary findings that the burden of inherited PTVs and copy number deletions among autistic individuals was elevated compared to their non-autistic siblings (P=4.00 × 10-5). Integration of multiple genetic factors will help us better understand the etiology of autism.</div></div>","PeriodicalId":12049,"journal":{"name":"European Neuropsychopharmacology","volume":"87 ","pages":"Page 16"},"PeriodicalIF":6.1000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Neuropsychopharmacology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0924977X2400244X","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Autism is highly heritable and has been associated with multiple classes of genetic variation. Common genetic variation contributes substantially to autism. Previously, with 18,381 autistic individuals and 27,969 non-autistic individuals, five genome-wide significant loci were identified. Now with 38,717 autistic individuals and 232,725 non-autistic individuals, we report an updated genome-wide association study (GWAS) of autism with 12 genome-wide significant loci. We observe a moderate genetic correlation (0.675, SE=0.0434) between Europe-based (Nautistic=22,643; Nnon-autistic=204,389) and United States-based (Nautistic =16,074; Nnon-autistic=28,346) autism cohorts, which contributes to the decline of the estimated single nucleotide polymorphism (SNP) heritability (from 0.118 (SE=0.010) to 0.068 (SE=0.003)). The genetic correlation between autism with intellectual disability (ID) (Nautistic=6,590; Nnon-autistic= 43,071; h2=0.062; SE=0.012) and autism without ID (Nautistic=23,173; Nnon-autistic= 204,679; h2=0.089; SE=0.005) is 0.658 (SE=0.086). In the United States family-based cohorts, the genetic correlation between autism with ID (Nfamily=3,993; h2=0.159; SE=0.033) and autism without ID (Nfamily=4,357; h2=0.171; SE=0.031) is 0.812 (SE=0.157). Autism without ID was positively genetically correlated with educational attainment (0.163; P=4.84 × 10-11) and intelligence (0.233; P=1.95 × 10-11). Autism with ID genetically correlated with neither educational attainment (0.036; P=0.409) nor intelligence (-0.072; P=0.235). As ID alone is negatively genetically correlated with intelligence, the lack of correlation between autism with ID and intelligence strongly suggests that autism with ID is genetically different from ID alone. This difference has implications for both research and clinical nosology. Rare and de novo variants contribute substantially to autism in some individuals. Through rare variant analyses, 72 genes have been associated with autism at a genome-wide significant level to date. While de novo protein truncating variants (PTVs) and copy number deletions have been associated with autism, we report preliminary findings that the burden of inherited PTVs and copy number deletions among autistic individuals was elevated compared to their non-autistic siblings (P=4.00 × 10-5). Integration of multiple genetic factors will help us better understand the etiology of autism.
期刊介绍:
European Neuropsychopharmacology is the official publication of the European College of Neuropsychopharmacology (ECNP). In accordance with the mission of the College, the journal focuses on clinical and basic science contributions that advance our understanding of brain function and human behaviour and enable translation into improved treatments and enhanced public health impact in psychiatry. Recent years have been characterized by exciting advances in basic knowledge and available experimental techniques in neuroscience and genomics. However, clinical translation of these findings has not been as rapid. The journal aims to narrow this gap by promoting findings that are expected to have a major impact on both our understanding of the biological bases of mental disorders and the development and improvement of treatments, ideally paving the way for prevention and recovery.